Candidemia after endoscopic retrograde cholangiopancreatography in an immunocompetent patient: A case report and literature review

Saudi J Gastroenterol. 2018 Mar-Apr;24(2):135-137. doi: 10.4103/sjg.SJG_536_17.

Abstract

Candidemia is a rare adverse event of endoscopic retrograde cholangiopancreatography (ERCP). To date, several case reports of post-ERCP candidemia have been reported. Recently, we experienced a case of disseminated candidemia caused by Candida albicans with secondary complications of acute respiratory distress syndrome, acute kidney injury, and hematogenous candidal endophthalmitis following ERCP in a young healthy patient without well-recognized risk factors for candidemia. After intravenous and intravitreal antifungal therapy and intensive care, the candidemia resolved, and the patient was discharged without further sequela. The present case alerted us to consider candidemia as a rare but potentially fatal adverse event of ERCP, even in an immunocompetent host.

Keywords: Adverse event; candidemia; endoscopic retrograde cholangiopancreatography.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acute Kidney Injury / drug therapy
  • Acute Kidney Injury / etiology
  • Administration, Intravenous
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / therapeutic use
  • Candida albicans / isolation & purification*
  • Candidemia / complications
  • Candidemia / drug therapy
  • Candidemia / microbiology*
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Endophthalmitis / drug therapy
  • Endophthalmitis / etiology
  • Humans
  • Immunocompetence
  • Intravitreal Injections
  • Male
  • Respiratory Distress Syndrome / drug therapy
  • Respiratory Distress Syndrome / etiology
  • Treatment Outcome
  • Young Adult

Substances

  • Antifungal Agents